{"id":"https://openalex.org/W2321970604","doi":"https://doi.org/10.1158/2326-6074.tumimm14-pr07","title":"Abstract PR07: Agonistic CD40 antibody combined with chemotherapy drives TLR4/MyD88 independent regression of pancreatic tumors in a T cell dependent manner","display_name":"Abstract PR07: Agonistic CD40 antibody combined with chemotherapy drives TLR4/MyD88 independent regression of pancreatic tumors in a T cell dependent manner","publication_year":2015,"publication_date":"2015-10-01","ids":{"openalex":"https://openalex.org/W2321970604","doi":"https://doi.org/10.1158/2326-6074.tumimm14-pr07","mag":"2321970604"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6074.tumimm14-pr07","doi":"https://doi.org/10.1158/2326-6074.tumimm14-pr07","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm14-pr07","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023887178","display_name":"Katelyn T. Byrne","orcid":"https://orcid.org/0000-0002-2459-9041","observed_orcids":["https://orcid.org/0000-0002-2459-9041"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katelyn T. Byrne","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040750947","display_name":"Robert H. Vonderheide","orcid":"https://orcid.org/0000-0002-7252-954X","observed_orcids":["https://orcid.org/0000-0002-7252-954X"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert H. Vonderheide","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I79576946"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"3","issue":"10_Supplement","first_page":"PR07","last_page":"PR07"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9125999808311462,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9125999808311462,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.042100001126527786,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.02669999934732914,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9240000247955322},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.953000009059906},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6899999976158142},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.8009999990463257},{"id":"https://openalex.org/keywords/foxp3","display_name":"Foxp3","score":0.7559999823570251},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.6439999938011169},{"id":"https://openalex.org/keywords/tlr4-myd88-signaling","display_name":"TLR4/MyD88 signaling","score":0.75}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.7068779468536377},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6720118522644043},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.5984455943107605},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5271425247192383},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.5182014107704163},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49221840500831604},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.46914902329444885},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.44587329030036926},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4396968483924866},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.42784979939460754},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38456428050994873},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3749426603317261},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33236587047576904},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31179141998291016},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6074.tumimm14-pr07","doi":"https://doi.org/10.1158/2326-6074.tumimm14-pr07","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm14-pr07","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2172408598","https://openalex.org/W2003298559","https://openalex.org/W2887004316","https://openalex.org/W2330572955","https://openalex.org/W4245966753","https://openalex.org/W4309113423","https://openalex.org/W2019420147","https://openalex.org/W2043991982","https://openalex.org/W4309194054","https://openalex.org/W2562806786"],"abstract_inverted_index":{"Abstract":[0],"Pancreatic":[1],"ductal":[2],"adenocarcinoma":[3],"(PDA)":[4],"is":[5,11,479],"a":[6,238,250,286,427,447,507],"highly":[7,469],"aggressive":[8],"cancer":[9],"that":[10,35,73,157,458],"resistant":[12],"to":[13,52,98,262,282,365,401,443],"most":[14],"treatments,":[15],"and":[16,47,66,81,164,178,276,308,318,372,408,522],"more":[17,142],"than":[18,143],"90%":[19],"of":[20,29,60,120,145,216,254,269,280,291,315,334,351,369,383,439,503,515],"patients":[21],"with":[22,39,94,131,148,169,227,237,389,497],"metastatic":[23],"PDA":[24,102,392],"die":[25],"within":[26,175,296],"five":[27],"years":[28],"diagnosis.":[30],"Recent":[31],"clinical":[32,437],"studies":[33,155,432],"show":[34],"combining":[36],"gemcitabine":[37],"(Gem)":[38],"nanoparticle":[40],"albumin-bound":[41],"paclitaxel,":[42],"Abraxane":[43],"(Abrx),":[44],"prolongs":[45],"progression-free":[46],"overall":[48,198],"survival":[49],"as":[50,329,331,380,446,482],"compared":[51],"Gem":[53],"alone,":[54,140],"but":[55,452],"the":[56,61,112,179,197,204,214,252,278,289,292,306,348,354,370,384,436,516],"objective":[57],"response":[58,387],"rate":[59],"combination":[62],"was":[63,160,222,264,271],"only":[64,124,434],"23%,":[65],"nearly":[67],"every":[68],"patient":[69],"eventually":[70],"progressed.":[71],"Given":[72],"CD40":[74,90,441,494],"activation":[75,349,442],"can":[76,463],"reverse":[77],"tumor-induced":[78],"immune":[79,386,461],"suppression":[80],"promote":[82,360],"anti-tumor":[83,385],"T":[84,161,190,200,218,245,259,459,508],"cell":[85,108,162,191,201,460,509],"responses,":[86],"we":[87],"administered":[88],"agonistic":[89],"monoclonal":[91],"antibody":[92,495],"(FGK45)":[93],"combined":[95,424,496],"Gem/Abrx":[96,423],"chemotherapy":[97,132,233,445,498],"mice":[99,129,146,167,180,397],"bearing":[100],"subcutaneous":[101],"tumors":[103,171,393,505],"established":[104],"using":[105],"syngeneic":[106],"tumor":[107,126,151,182,205,307,410,418,471],"lines":[109],"derived":[110],"from":[111],"KrasG12D+/-;Trp53R172H+/-;Pdx-1":[113],"Cre":[114],"(KPC)":[115],"genetically":[116],"engineered":[117],"mouse":[118],"model":[119],"PDA.":[121,195],"We":[122],"found":[123],"rare":[125],"regressions":[127,152],"in":[128,165,203,242,277,288,305,323,339,347,353,395,422,426,506],"treated":[130,147,168],"alone":[133],"(Gem,":[134],"Abrx,":[135],"or":[136,138,234,257,417],"Gem/Abrx)":[137],"FGK45":[139,235],"whereas":[141],"50%":[144],"Gem/Abrx/FGK45":[149,228,230,300,355,366,402],"experienced":[150],"(p<0.0001).":[153],"Mechanistic":[154],"revealed":[156],"this":[158,467],"effect":[159],"dependent,":[163],"some":[166],"Gem/Abrx/FGK45,":[170],"were":[172,398],"completely":[173],"rejected":[174],"3":[176],"weeks":[177],"remained":[181],"free":[183],"for":[184,450],"over":[185],"100":[186],"days,":[187],"suggesting":[188,285],"long-lived":[189],"memory":[192],"directed":[193],"against":[194,466],"Although":[196],"CD3+":[199],"population":[202],"after":[206,225,274,299,412],"therapy":[207],"did":[208],"not":[209,433],"vary":[210],"across":[211],"treatment":[212,226,231,413],"cohorts,":[213],"proportion":[215],"FoxP3+CD4+":[217],"regulatory":[219],"cells":[220,247,261,303],"(Tregs)":[221],"reduced":[223],"6.9-fold":[224],"(p<0.05,":[229],"versus":[232,321,337,420],"alone),":[236],"concurrent":[239],"1.75-fold":[240],"increase":[241],"activated":[243],"CD44hiCD4+":[244],"helper":[246],"(p<0.01).":[248],"As":[249],"result,":[251],"ratio":[253],"CD4":[255,293],"Thelper":[256,283,361],"CD8":[258,428],"effector":[260],"Tregs":[263,270],"increased":[265,313,332],"intratumorally.":[266],"The":[267],"reduction":[268],"observed":[272],"early":[273],"therapy,":[275,403],"absence":[279],"Treg":[281],"conversion,":[284],"change":[287],"priming":[290],"compartment.":[294],"Indeed,":[295],"24":[297],"hours":[298],"treatment,":[301],"antigen-presenting":[302],"(APCs)":[304],"draining":[309],"lymph":[310],"node":[311],"had":[312],"expression":[314],"both":[316],"CD86":[317],"MHCII":[319],"(37%":[320],"10%":[322],"control":[324,340],"group,":[325,341],"p<0.0001":[326,342],"by":[327,343,474],"ANOVA),":[328],"well":[330],"production":[333],"TNF-alpha":[335],"(39%":[336],"24%":[338],"ANOVA).":[344],"These":[345,431],"changes":[346],"status":[350],"APCs":[352],"treated-tumor":[356],"microenvironment":[357],"may":[358],"help":[359],"differentiation.":[362],"Furthermore,":[363],"responses":[364],"are":[367],"independent":[368,501],"TLR4":[371],"MyD88":[373],"pathways,":[374],"which":[375],"have":[376],"previously":[377],"been":[378],"reported":[379],"critical":[381],"mediators":[382],"generated":[388],"chemotherapy.":[390],"Spontaneous":[391],"arising":[394],"KPC":[396],"also":[399,453,480],"susceptible":[400],"exhibiting":[404],"slowed":[405],"growth":[406],"rates":[407],"even":[409],"regression":[411,502],"(37.5%":[414],"stable":[415],"disease":[416],"regression,":[419],"0%":[421],"group),":[425],"dependent":[429,510],"manner.":[430,511],"highlight":[435],"potential":[438],"adding":[440],"standard-of-care":[444],"novel":[448],"strategy":[449],"PDA,":[451],"underscore":[454],"an":[455],"emerging":[456],"hypothesis":[457],"surveillance":[462],"be":[464],"effective":[465],"otherwise":[468],"immunosuppressive":[470],"if":[472],"triggered":[473],"robust":[475],"vaccination.":[476],"This":[477],"abstract":[478],"presented":[481],"Poster":[483],"A40.":[484],"Citation":[485],"Format:":[486],"Katelyn":[487],"T.":[488],"Byrne,":[489],"Robert":[490],"H.":[491],"Vonderheide.":[492],"Agonistic":[493],"drives":[499],"TLR4/MyD88":[500],"pancreatic":[504],"[abstract].":[512],"In:":[513],"Proceedings":[514],"AACR":[517],"Special":[518],"Conference:":[519],"Tumor":[520],"Immunology":[521],"Immunotherapy:":[523],"A":[524],"New":[525],"Chapter;":[526],"December":[527],"1-4,":[528],"2014;":[529],"Orlando,":[530],"FL.":[531],"Philadelphia":[532],"(PA):":[533],"AACR;":[534],"Cancer":[535],"Immunol":[536],"Res":[537],"2015;3(10":[538],"Suppl):Abstract":[539],"nr":[540],"PR07.":[541]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-06-24T00:00:00"}